KKR buys another hospital in India for $1.3 billion, marks largest deal cheque by American investment giant

Private equity’s love affair with Indian healthcare is showing no signs of slowing — and KKR is making one of its biggest bets yet. The global investment firm is acquiring Medicover India — the Indian hospital arm of Sweden’s Medicover AB — in a deal valuing the business at $1.3 billion.

KKR Picks Up Medicover

Here’s the structure. Medicover held 66.1% of its Indian hospital business, with minority partners holding the remaining 33.9%. KKR is buying the entire 100% — a clean, full exit for Medicover from India. In return, Medicover walks away with 740 million euros in gross cash proceeds.

Some context on how we got here. Medicover entered India back in 2017 — as a minority shareholder — and today Medicover has 24 hospitals and roughly 4,800 beds across South and West India. As of June this year, the business was generating annual revenue of 220.5 million euros — that’s over 2000 crores.

Medicover had actually been evaluating an India IPO as an alternative path since December last year — but ultimately concluded a sale to KKR was the better route, freeing up capital to double down on its core European markets — Poland, Germany, and Romania.

What Does This Deal Mean?

Now, why does this matter for KKR? Because this isn’t a first-time bet — it’s a pattern. Since 2004, KKR has deployed over 20 billion dollars into healthcare globally. In India specifically — this goes back to 2018, when KKR first entered Max Healthcare with a 293 million dollar investment. It fully exited in 2022, selling its stake for about 1.16 billion dollars — a five-x return, and at the time, KKR’s largest India exit ever.

Since then, KKR’s been building right back up — Healthium Medtech in 2024 for 839 million dollars, a controlling stake in Kerala’s Baby Memorial Hospital the same year, and just last year — a 54% stake in HCG from CVC Capital for 400 million dollars. Medicover now becomes one of KKR’s largest active healthcare bet in India.

And this fits a much bigger picture. Indian healthcare has drawn over 11 billion dollars in cumulative private equity investment since the pandemic. Deal volumes have more than tripled since 2020 — and this Medicover transaction could be an early signal that 2026 builds on that momentum even further.The deal still needs regulatory clearance and is expected to close in the fourth quarter of this year.

Also Read: Legal Digest | Proceedings against the deceased is non est: Allahabad HC